Prognostic Biomarkers for Anti-PD-1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma抗PD-1单克隆抗体在晚期黑色素瘤一线治疗中的预后生物标志物International Journal of DermatologyIF3.22025-06-270OAAI
Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanomaINTERNATIONAL JOURNAL OF DERMATOLOGYIF3.22024-06-070PRE
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82024-02-260PRE
Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech RepublicDERMATOLOGIC THERAPYIF3.42023-03-151OA
Corticosteroid rescue therapy in relapsing hidradenitis suppurativa treated with adalimumabJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82021-02-134PREAI
Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alphaBRITISH JOURNAL OF DERMATOLOGYIF9.62021-02-0120PREAI
Home-based training using neuromuscular electrical stimulation in patients on continuous ambulatory peritoneal dialysis: A pilot studyartificial organsIF2.32019-02-113PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向